Phase I Study of the Safety and Immunogenicity of Na-GST-1/Alhydrogel With Different Doses of the Novel Immunostimulant GLA-AF in Healthy Adults.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hookworm vaccine (Primary) ; Aluminium hydroxide; Glycopyranosyl lipid adjuvant
- Indications Hookworm infections
- Focus Adverse reactions; Pharmacodynamics
- 22 Jun 2017 Biomarkers information updated
- 16 Sep 2013 Planned end date changed from 1 Dec 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 16 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.